Our data, showing elevated circulating concentrations of IL-1β, IL-6, TNFα and CRP are consistent with both clinical and laboratory evidence showing increased chronic systemic inflammation in COPD. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.